Long-Term Safety Of PF-00547659 In Ulcerative Colitis

Summary

Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 144 weeks of open-label treatment to evaluate the long-term safety of the drug.

Timeline

Start

2013-03-18

Primary completion

2017-12-13

Completion

2017-12-13

Drugs

Indications